Vacuum Negative Pressure Isolation Strategies in the Age of ADCs
With the rise of Antibody-Drug Conjugates (ADCs), the pressure to handle Highly Potent Active Pharmaceutical Ingredients (HPAPIs) has reached its peak. At OEB 5/6 levels, exposure limits are often below 10 ng/m³. In this environment, a vacuum glove box is not just equipment; it is a critical life-safety system.
Deep Negative Pressure Control
For highly sensitizing drugs, the industry has standardized the use of active negative-pressure vacuum isolators.
- Pressure Gradients: Systems are regulated via PLC to maintain a deep negative pressure between -150 Pa and -250 Pa.
- Breach Compensation: 2026 technology ensures that even if a glove is punctured, the vacuum pump group instantly increases suction to maintain an inward velocity of $\ge 0.5\text{ m/s}$ at the breach, preventing any powder egress.
Core Safety Strategies
- Surrogate Testing: Rigorous residue validation is performed using materials like Naproxen Sodium.
- Dual-Stage Vacuum Filtration: Utilizing redundant HEPA filtration combined with vacuum-end exhaust treatment modules.
- VHP Sterilization: Integrated Vaporized Hydrogen Peroxide systems achieve deeper micro-pore sterilization through vacuum-assisted penetration.